For example, VEGF, originally identified as an endothelial cell‐specific growth factor that stimulates angiogenesis, has recently been deemed responsible for increased vascular permeability, resulting in augmented leukocyte recruitment at the site of inflammation, which could be central for the development of SS lesions [48]. This evidence concerns the gene VEGFA and synovial sarcoma.